Founded in 1968, the JSDT has over 16,000 members and is one of the largest societies in Japan. The JSDT promote advances in technology, research and the dissemination of knowledge related to renal replacement medicine. Japan remains a leader in renal replacement therapy including dialysis therapy, and the JSDT play a significant role in proposing clinical guidelines to improve the life prognosis and QOL of CKD patients.
Japanese Society for Dialysis Therapy (JSDT)
Annual Journal Metrics
45 days to first decision for reviewed manuscripts only
45 days to first decision for all manuscripts
128 days from submission to acceptance
27 days from acceptance to publication
23 Altmetric mentions